Status:
COMPLETED
Generalized Neonatal Screening of Severe Combined Immunodeficiencies
Lead Sponsor:
Nantes University Hospital
Conditions:
Severe Combined Immunodeficiency, Atypical
Eligibility:
All Genders
3-18 years
Phase:
NA
Brief Summary
Severe combined Immunodeficiencies ( SCID ) are a group of inherited diseases of the immune system by characterised profound abnormalities of T cell development . Infants with SCID require prompt clin...
Detailed Description
The project proposes to study the feasibility and cost-effectiveness ratio ( time management and life expectancy to 10 years) of generalized neonatal screening for SCID children by offering this scree...
Eligibility Criteria
Inclusion
- Screening Group: Newborn on day 3 of birth (premature and non premature)
- Control group: Patients diagnosed with SCID without screening at participating centers
Exclusion
- Lack of parental consent
- Children whose parents are adults under guardianship,
- Children without health insurance, for the screening group:
- The early exit of the child from the maternity hospital
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2018
Estimated Enrollment :
190539 Patients enrolled
Trial Details
Trial ID
NCT02244450
Start Date
December 1 2014
End Date
April 28 2018
Last Update
July 24 2018
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Angers Private Hospital Clinique de l'Anjou
Angers, France
2
Angers University Hospital
Angers, France
3
Argenteuil Hospital
Argenteuil, France
4
Aulnay-sous-Bois Hospital CHI Robert Ballanger
Aulnay-sous-Bois, France